Meeting
2013 Genitourinary Cancers Symposium
Pre-cystectomy serum levels of CA19-9, CA125, and CEA: Correlation with pathologic stage and oncologic outcome in urothelial carcinoma of bladder.
Authors
Hamed Ahmadi
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA
Hamed Ahmadi , Hooman Djaladat , Gus Miranda , Jie Cai , Siamak Daneshmand
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 303)
DOI
10.1200/jco.2013.31.6_suppl.303
Abstract #
303
Poster Bd #
H14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Utility of tumor marker levels in predicting survival of patients with appendiceal adenocarcinoma.
First Author: Abdelrahman M.G. Yousef
Poster
2015 ASCO Annual Meeting
Serum tumor marker utilization in patients with advanced solid tumors.
First Author: Melissa Kate Accordino
Poster
2023 ASCO Annual Meeting
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response: A translational sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
First Author: Bonnita Werner
Poster
2023 ASCO Annual Meeting
GaEsSeer: Early detection of gastric and esophageal cancer by integrating methylation and fragmentomics signatures in cfDNA.
First Author: Yunshi Zhong